We are live on ! Find out more
VXRT

Vaxart
VXRT

Delisted

VXRT was delisted on the 7th of July, 2025.

Back to rankings

59 hedge funds and large institutions have $77.3M invested in Vaxart in 2014 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 22 increasing their positions, 8 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

567% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 3

236% more capital invested

Capital invested by funds: $23M → $77.3M (+$54.3M)

175% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 8

40% more funds holding

Funds holding: 42 → 59 (+17)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $175K

Holders
59
Holders Change
+17
Holders Change %
+40.48%
% of All Funds
1.7%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
22
Reduced
8
Closed
3
Calls
–
Puts
$175K
Net Calls
-$175K
Net Calls Change
-$70K

Top Buyers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
+$13.9M
2
HM
HealthCor Management
New York
+$6.47M
3
BC
Broadfin Capital
New York
+$3.58M
4
VAM
Visium Asset Management
New York
+$3.37M
5
BI
BVF Inc
California
+$2.45M

Top Sellers

Rank Fund Capital Flow
1
6CM
683 Capital Management
New York
-$1.56M
2
TL
TowerView LLC
New York
-$815K
3
GCIA
Gabelli & Co Investment Advisers
New York
-$422K
4
Deutsche Bank
Deutsche Bank
Germany
-$321K
5
BA
BlackRock Advisors
Delaware
-$134K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
26
Vanguard Group
Pennsylvania
$637K +$378K +6,105 +181%
BFA
27
BlackRock Fund Advisors
California
$558K +$145K +2,345 +39%
Susquehanna International Group
28
Susquehanna International Group
Pennsylvania
$555K +$511K +8,262 New
DD
29
Dominick & Dominick
New York
$538K – – –
U
30
UBS
Switzerland
$515K +$471K +7,618 +19,533%
BIM
31
Bogle Investment Management
Massachusetts
$469K +$432K +6,979 New
Citadel Advisors
32
Citadel Advisors
Florida
$438K +$403K +6,523 New
Goldman Sachs
33
Goldman Sachs
New York
$427K +$35.7K +578 +10%
Northern Trust
34
Northern Trust
Illinois
$410K +$151K +2,437 +66%
PAM
35
Panagora Asset Management
Massachusetts
$370K +$340K +5,500 New
SKK
36
Shepherd Kaplan Krochuk
Massachusetts
$366K +$54K +873 +19%
CS
37
Credit Suisse
Switzerland
$330K +$304K +4,917 New
SIM
38
Spark Investment Management
New York
$267K +$145K +2,337 +142%
BCMU
39
BlueCrest Capital Management (UK)
Guernsey
$249K +$229K +3,700 New
SFM
40
Soros Fund Management
New York
$241K +$222K +3,591 New
Jane Street
41
Jane Street
New York
$239K +$220K +3,558 New
LP
42
LMR Partners
United Kingdom
$182K +$168K +2,720 New
State Street
43
State Street
Massachusetts
$174K – – –
Charles Schwab
44
Charles Schwab
California
$159K +$146K +2,365 New
GF
45
Gabelli Funds
New York
$131K -$91.7K -1,482 -43%
Connor, Clark & Lunn Investment Management (CC&L)
46
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$129K +$25.3K +409 +31%
GCP
47
GSA Capital Partners
United Kingdom
$111K +$102K +1,645 New
Wells Fargo
48
Wells Fargo
California
$100K +$91.5K +1,480 +11,385%
N
49
Natixis
France
$96K +$88.3K +1,427 New
GC
50
Guggenheim Capital
Illinois
$87K +$80K +1,294 New
1
2
3

VXRT Hedge Fund Activity: Q1 2014 in Review

59 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q1 2014, worth a combined $77.3M — up 236% from $23M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new VXRT positions and 3 closed out — a net gain of 17 holders — while 22 added to existing stakes and 8 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $13.9M. The largest seller was 683 Capital Management, cutting an estimated $1.56M.

  • 59 institutional investors held Vaxart (VXRT) as of Q1 2014, up from 42 in Q4 2013.
  • Funds reported $77.3M of Vaxart stock for Q1 2014, up 236% quarter-over-quarter.
  • 20 funds opened new Vaxart positions in Q1 2014 and 3 closed out, a net change of +17 holders.
  • The largest Vaxart buyer in Q1 2014 was JP Morgan Chase, an estimated $13.9M added.
  • The largest Vaxart seller in Q1 2014 was 683 Capital Management, an estimated $1.56M sold.

Based on aggregated 13F filings for Q1 2014.